For the purpose of these regulations the
terms used herein are defined as follows:
"ADAP" means the AIDS Drug Assistance Program, the federal earmark in the Ryan
White Part B grant providing funding for HIV Clients' medications, which
encompasses HDAP and IAP.
"AIDS" means Acquired Immune Deficiency Syndrome or Acquired Immunodeficiency
(c) "Certification" means
the determination that an applicant meets the eligibility criteria to receive
assistance through the Ryan White Program.
(d) "Client" means a person enrolled in the
Ryan White Program.
"Department" means the Tennessee Department of Health.
(f) "FDA" means the U.S. Food and Drug
means the HDAP Formulary, which lists the FDA approved medications provided by
Tennessee's HDAP Program.
"HDAP" means the HIV Drug Assistance Program, a program through which the
Department provides Formulary medications to Clients.
(i) "HIV" means Human Immunodeficiency
(j) "IAP" means Insurance
Assistance Program, a program through which the Department provides assistance
paying health insurance premiums, co-payments, and/or deductibles for eligible
(k) "Priority Group" means
those eligible for temporary emergency access to HDAP or IAP services if there
is a waiting list.
Director" means the Department employee responsible for the overall management
of grants and programs in the HIV/AIDS/STD Section of the Department.
(m) "Provider" means a health care
professional with prescriptive authority, licensed pursuant to Title 63 of the
(n) "Ryan White
Program" means the Departmental program that receives federal Ryan White Part B
funding and provides medical services, medications, and support services to
"TennCare" means Tennessee's State Medicaid Program.